These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 809065)

  • 21. Large scale isolation of functionally active components of the human complement system.
    Hammer CH; Wirtz GH; Renfer L; Gresham HD; Tack BF
    J Biol Chem; 1981 Apr; 256(8):3995-4006. PubMed ID: 6783652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death.
    Joiner KA; Hammer CH; Brown EJ; Cole RJ; Frank MM
    J Exp Med; 1982 Mar; 155(3):797-808. PubMed ID: 6801179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human peritoneal macrophages. Production in vitro of the active terminal complement components C5 to C9 and a functional alternative pathway of complement. Brief report.
    Hetland G; Bungum L
    APMIS; 1988 Jan; 96(1):89-92. PubMed ID: 3345254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Separation of six bovine complement components and one inactivator (1, 2).
    Barta O; Nelson RA; Kuo CY
    Immunol Commun; 1976; 5(1-2):75-86. PubMed ID: 950248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement system in human colostrum: presence of nine complement components and factors of alternative pathway in human colostrum.
    Nakajima S; Baba AS; Tamura N
    Int Arch Allergy Appl Immunol; 1977; 54(5):428-33. PubMed ID: 885627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunoenzyme determination of the C5b-9 complex of the complement system].
    Rus H; Niculescu F; Cristea A; Vlaicu R
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1986; 31(1):35-40. PubMed ID: 3738363
    [No Abstract]   [Full Text] [Related]  

  • 27. On the mechanism of cytolysis by complement: evidence on insertion of C5b and C7 subunits of the C5b,6,7 complex into phospholipid bilayers of erythrocyte membranes.
    Hammer CH; Nicholson A; Mayer MM
    Proc Natl Acad Sci U S A; 1975 Dec; 72(12):5076-80. PubMed ID: 1061092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular analysis of the membrane attack mechanism of complement.
    Kolb WP; Haxby JA; Arroyave CM; Müller-Eberhard HJ
    J Exp Med; 1972 Mar; 135(3):549-66. PubMed ID: 5058233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human umbilical vein endothelial cells synthesize functional C3, C5, C6, C8 and C9 in vitro.
    Johnson E; Hetland G
    Scand J Immunol; 1991 Jun; 33(6):667-71. PubMed ID: 2047760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human complement in the arachidonic acid transformation pathway in platelets.
    Polley MJ; Nachman RL; Weksler BB
    J Exp Med; 1981 Feb; 153(2):257-68. PubMed ID: 7241047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoabsorption of membrane-specific antibodies for determination of exposed and hidden proteins in human erythrocyte membranes.
    Bjerrum OJ; Lundahl P; Brogren CH; Hjertén S
    Biochim Biophys Acta; 1975 Jun; 394(2):173-81. PubMed ID: 49198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane.
    Joiner KA; Hammer CH; Brown EJ; Frank MM
    J Exp Med; 1982 Mar; 155(3):809-19. PubMed ID: 6801180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of aging on complement activity (CH50) and complement protein levels.
    Nagaki K; Hiramatsu S; Inai S; Sasaki A
    J Clin Lab Immunol; 1980 Jan; 3(1):45-50. PubMed ID: 7381926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.
    Hammer CH; Abramovitz AS; Mayer MM
    J Immunol; 1976 Sep; 117(3):830-4. PubMed ID: 956655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyanate as an inactivator of complement proteins.
    Schultz DR; Arnold PI
    J Immunol; 1975 Dec; 115(6):1558-65. PubMed ID: 1184967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemolytic complement activity in normal human donor corneas.
    Mondino BJ; Hoffman DB
    Arch Ophthalmol; 1980 Nov; 98(11):2041-4. PubMed ID: 7002126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of complement components C5, C6, C7, C8 and C9 in vitro by human monocytes and assembly of the terminal complement complex.
    Hetland G; Johnson E; Falk RJ; Eskeland T
    Scand J Immunol; 1986 Oct; 24(4):421-8. PubMed ID: 3764345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
    Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
    Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The terminal membrane C5b-9 complex of human complement. Evidence for the existence of multiple protease-resistant polypeptides that form the trans-membrane complement channel.
    Bhakdi S; Tranum-Jensen J; Klump O
    J Immunol; 1980 May; 124(5):2451-7. PubMed ID: 6154104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.